In cancer cells, NCOA4 is a critical regulator of ferroptosis, and mutations in NCOA4 can lead to decreased ferroptosis of tumor cells by reducing intracellular free iron accumulation, glutathione synthesis, and reactive oxygen species, among other effects (ROS). This evidence concerns the gene NCOA4 and cancer.